Vertex Pharmaceuticals Inc (VRTX) Insider Trading
- $12,939,410.00
- $1,027,201,493.43
- March 10, 2025
- Joshua S Boger
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 4, 2016 | Director | 1,125 | $122.21 | Sell | $137,486.25 | |
| Dec. 30, 2015 | Director | 10,400 | $127.15 | Sell | $1,322,360.00 | |
| Dec. 21, 2015 | Director | 10,400 | $119.26 | Sell | $1,240,304.00 | |
| Dec. 9, 2015 | Director | 10,400 | $120.80 | Sell | $1,256,320.00 | |
| Dec. 4, 2015 | EVP | 4,531 | $123.98 | Sell | $561,753.38 | |
| Dec. 2, 2015 | Director | 10,400 | $130.91 | Sell | $1,361,464.00 | |
| Dec. 1, 2015 | Director | 1,125 | $129.65 | Sell | $145,856.25 | |
| Dec. 1, 2015 | EVP | 5,000 | $131.00 | Sell | $655,000.00 | |
| Nov. 23, 2015 | Director | 10,400 | $132.18 | Sell | $1,374,672.00 | |
| Nov. 11, 2015 | Director | 10,400 | $118.59 | Sell | $1,233,336.00 | |
| Nov. 4, 2015 | Director | 10,400 | $124.23 | Sell | $1,291,992.00 | |
| Nov. 2, 2015 | Director | 1,125 | $126.19 | Sell | $141,963.75 | |
| Oct. 28, 2015 | Director | 10,400 | $119.01 | Sell | $1,237,704.00 | |
| Oct. 21, 2015 | Director | 10,400 | $108.82 | Sell | $1,131,728.00 | |
| Oct. 14, 2015 | Director | 10,400 | $112.62 | Sell | $1,171,248.00 | |
| Oct. 7, 2015 | Director | 10,400 | $109.61 | Sell | $1,139,944.00 | |
| Oct. 2, 2015 | Director | 20,000 | $110.00 | Sell | $2,200,000.00 | |
| Oct. 1, 2015 | Director | 1,125 | $104.64 | Sell | $117,720.00 | |
| Oct. 1, 2015 | EVP | 12,417 | $104.71 | Sell | $1,300,184.07 | |
| Sept. 30, 2015 | Director | 10,400 | $103.14 | Sell | $1,072,656.00 | |
| Sept. 23, 2015 | Director | 10,400 | $111.89 | Sell | $1,163,656.00 | |
| Sept. 16, 2015 | Director | 10,400 | $133.24 | Sell | $1,385,696.00 | |
| Sept. 9, 2015 | Director | 10,400 | $131.41 | Sell | $1,366,664.00 | |
| Sept. 4, 2015 | EVP | 9,063 | $125.77 | Sell | $1,139,853.51 | |
| Sept. 2, 2015 | Director | 10,400 | $125.85 | Sell | $1,308,840.00 | |
| Sept. 1, 2015 | Director | 1,125 | $125.40 | Sell | $141,075.00 | |
| Aug. 26, 2015 | Director | 10,400 | $124.71 | Sell | $1,296,984.00 | |
| Aug. 19, 2015 | Director | 10,400 | $139.93 | Sell | $1,455,272.00 | |
| Aug. 12, 2015 | Director | 10,400 | $135.83 | Sell | $1,412,632.00 | |
| July 22, 2015 | Director | 10,400 | $130.92 | Sell | $1,361,568.00 | |
| July 15, 2015 | Director | 12,200 | $133.98 | Sell | $1,634,556.00 | |
| July 13, 2015 | SVP | 1,125 | $123.79 | Sell | $139,263.75 | |
| July 8, 2015 | Director | 11,700 | $122.74 | Sell | $1,436,058.00 | |
| July 2, 2015 | CMO | 2,291 | $129.36 | Sell | $296,363.76 | |
| July 1, 2015 | Director | 11,700 | $125.60 | Sell | $1,469,520.00 | |
| June 24, 2015 | Director | 11,700 | $130.41 | Sell | $1,525,797.00 | |
| June 17, 2015 | Director | 11,700 | $123.90 | Sell | $1,449,630.00 | |
| June 10, 2015 | Director | 11,700 | $125.02 | Sell | $1,462,734.00 | |
| May 20, 2015 | Director | 11,700 | $126.73 | Sell | $1,482,741.00 | |
| May 6, 2015 | Director | 11,700 | $122.79 | Sell | $1,436,643.00 | |
| May 5, 2015 | SVP | 4,101 | $123.68 | Sell | $507,211.68 | |
| April 29, 2015 | Director | 11,700 | $124.59 | Sell | $1,457,703.00 | |
| April 27, 2015 | EVP | 61,480 | $129.36 | Sell | $7,953,052.80 | |
| April 27, 2015 | SVP | 1,125 | $129.74 | Sell | $145,957.50 | |
| April 27, 2015 | Director | 68,125 | $129.11 | Sell | $8,795,618.75 | |
| April 22, 2015 | Director | 11,700 | $132.46 | Sell | $1,549,782.00 | |
| April 15, 2015 | Director | 11,700 | $129.25 | Sell | $1,512,225.00 | |
| April 13, 2015 | SVP | 1,125 | $128.60 | Sell | $144,675.00 | |
| April 8, 2015 | Director | 11,700 | $123.26 | Sell | $1,442,142.00 | |
| April 6, 2015 | Director | 12,500 | $118.36 | Sell | $1,479,500.00 |
Insiders are both buying and selling Vertex Pharmaceuticals Inc stock.
The insider traders at Vertex Pharmaceuticals Inc are: Joshua S Boger, Paul M Silva, Stuart A Arbuckle, Jeffrey M Leiden, Amit Sachdev, Michael Parini, Jeffrey Chodakewitz, David Altshuler, Joshua S. Boger, Yuchun Lee, Reshma Kewalramani, Sangeeta N Bhatia, Ourania Tatsis, Ian F Smith, Bastiano Sanna, Bruce I Sachs, Joshua Boger, Peter Mueller, Charles F Wagner Jr, Carmen Bozic, Margaret G Mcglynn, Bruce Sachs, Elaine Ullian, Stuart A. Arbuckle, Kristen Ambrose, Jeffrey Leiden, Joy Liu, Kenneth L Horton, Megan E Pace, Megan Pace, Wayne Joseph Riley, Paul Silva, Thomas Graney, Christiana Stamoulis, Kenneth Horton, Sangeeta N. Bhatia, Ian F. Smith, Paul M. Silva, Terrence C Kearney, Thomas Connolly, Jeffrey M. Leiden, William D Young, Jonathan Biller, Edward Morrow Atkinson III, and Lloyd Carney
The most active insider trader at Vertex Pharmaceuticals Inc is Joshua S Boger with 99 trades.
Jeffrey M Leiden has sold the most Vertex Pharmaceuticals Inc stock with a total value of $395,375,749.22.
Reshma Kewalramani has bought the most Vertex Pharmaceuticals Inc stock with a total value of $17,310,520.00.
The most recent insider trade for Vertex Pharmaceuticals Inc was on March 10, 2025.
The single biggest insider buy for Vertex Pharmaceuticals Inc was from Reshma Kewalramani with a total value of $7,677,010.00 on July 30, 2024.
The single biggest insider sell for Vertex Pharmaceuticals Inc was from Jeffrey M Leiden with a total value of $37,164,389.02 on July 25, 2022.